A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors

PHASE1RecruitingINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

September 19, 2023

Primary Completion Date

September 30, 2025

Study Completion Date

March 31, 2026

Conditions

Solid TumorBreast CancerPancreatic CancerOvarian CancerColorectal Cancer

Interventions

DRUG

SON-DP

Solution for IV administration

Trial Locations (5)

RECRUITING

Carolina BioOncology Institute, Huntersville

RECRUITING

Henry Ford Health System, Detroit

RECRUITING

Stephenson Cancer Center, University of Oklahoma, Oklahoma City

RECRUITING

MD Anderson Cancer Center, Houston

RECRUITING

Banner MD Anderson Cancer Center (BMDACC), Gilbert

All Listed Sponsors

lead

Qurgen Inc.

INDUSTRY